Avondale Partners Downgrades Diplomat Pharmacy (DPLO) to Market Perform
Tweet
Share
E-mailGet Alerts DPLO Hot Sheet
Price: $4.00 --0%
Rating Summary:
2 Buy, 13 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 21
Rating Summary:
2 Buy, 13 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 21
Join SI Premium – FREE
Avondale Partners downgraded Diplomat Pharmacy (NYSE: DPLO) from Market Outperform to Market Perform.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $22.38 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades KOSE Corporation (4922:JP) (KSRYY) to Underweight
- BNP Paribas Exane Downgrades Lululemon (LULU) to Underperform
- Citi Downgrades BAIC Motor Corp Ltd. (1958:HK) (BCCMY) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Avondale PartnersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
